Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg negative chronic hepatitis B.

Kranidioti H, Manolakopoulos S, Kontos G, Breen MS, Kourikou A, Deutsch M, Quesada-Del-Bosque ME, Martinez-Nunez RT, Naiyer MM, Woelk CH, Sanchez-Elsner T, Hadziyannis E, Papatheodoridis G, Khakoo SI.

J Viral Hepat. 2019 Jan 31. doi: 10.1111/jvh.13068. [Epub ahead of print]

PMID:
30702196
2.

A novel antibody combination to identify KIR2DS2high natural killer cells in KIR2DL3/L2/S2 heterozygous donors.

Blunt MD, Rettman P, Bastidas-Legarda LY, Fulton R, Capizzuto V, Naiyer MM, Traherne JA, Khakoo SI.

HLA. 2019 Jan;93(1):32-35. doi: 10.1111/tan.13413.

PMID:
30381896
3.

KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C.

Naiyer MM, Cassidy SA, Magri A, Cowton V, Chen K, Mansour S, Kranidioti H, Mbiribindi B, Rettman P, Harris S, Fanning LJ, Mulder A, Claas FHJ, Davidson AD, Patel AH, Purbhoo MA, Khakoo SI.

Sci Immunol. 2017 Sep 15;2(15). pii: eaal5296. doi: 10.1126/sciimmunol.aal5296.

PMID:
28916719
4.

A peptide antagonist disrupts NK cell inhibitory synapse formation.

Borhis G, Ahmed PS, Mbiribindi B, Naiyer MM, Davis DM, Purbhoo MA, Khakoo SI.

J Immunol. 2013 Mar 15;190(6):2924-30. doi: 10.4049/jimmunol.1201032. Epub 2013 Feb 4.

5.

Identification and characterization of a human IL-10 receptor antagonist.

Naiyer MM, Saha S, Hemke V, Roy S, Singh S, Musti KV, Saha B.

Hum Immunol. 2013 Jan;74(1):28-31. doi: 10.1016/j.humimm.2012.09.002. Epub 2012 Sep 19.

PMID:
23000375

Supplemental Content

Loading ...
Support Center